Clearbridge Investments, LLC Novartis Ag Transaction History

Clearbridge Investments, LLC

  • $110 Billion
  • Q1 2025

A detailed history of Clearbridge Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,351 shares of NVS stock, worth $272,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,351
Previous 2,351 -0.0%
Holding current value
$272,151
Previous $228,000 14.91%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 27, 2024
BUY
$92.57 - $107.37 $217,632 - $252,426
2,351 New
2,351 $250,000
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $23,341 - $26,575
-245 Reduced 9.44%
2,351 $227,000
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $94,207 - $103,672
-1,021 Reduced 28.23%
2,596 $262,000
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $61,100 - $67,808
645 Added 21.7%
3,617 $368,000
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $462 - $524
-5 Reduced 0.17%
2,972 $299,000
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $880 - $1,020
-11 Reduced 0.37%
2,977 $273,000
Q4 2022

Feb 10, 2023
BUY
$75.55 - $92.52 $7,403 - $9,066
98 Added 3.39%
2,988 $271,000
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $383,719 - $448,778
-5,143 Reduced 64.02%
2,890 $220,000
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $23,511 - $27,375
-292 Reduced 3.51%
8,033 $679,000
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $2.48 Million - $2.81 Million
-30,990 Reduced 78.82%
8,325 $731,000
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $117,637 - $130,079
-1,476 Reduced 3.62%
39,315 $3.44 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $452,079 - $525,933
5,528 Added 15.68%
40,791 $3.34 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $200,825 - $221,817
-2,356 Reduced 6.26%
35,263 $3.22 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $129 Million - $152 Million
-1,539,513 Reduced 97.61%
37,619 $3.22 Million
Q4 2020

Feb 10, 2021
BUY
$78.07 - $94.43 $616,206 - $745,335
7,893 Added 0.5%
1,577,132 $149 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $25.9 Million - $28.6 Million
-314,736 Reduced 16.71%
1,569,239 $136 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $339,986 - $382,711
4,201 Added 0.22%
1,883,975 $165 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $10 Million - $14.1 Million
142,047 Added 8.17%
1,879,774 $155 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $14.5 Million - $16.4 Million
171,577 Added 10.96%
1,737,727 $165 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $6.1 Million - $6.72 Million
71,344 Added 4.77%
1,566,150 $136 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $18 Million - $22.2 Million
239,378 Added 19.07%
1,494,806 $0
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $32.5 Million - $37.1 Million
430,876 Added 52.26%
1,255,428 $121 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $3.11 Million - $3.46 Million
42,175 Added 5.39%
824,552 $70.8 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $4.82 Million - $5.57 Million
71,953 Added 10.13%
782,377 $67.4 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $284,630 - $321,683
4,385 Added 0.62%
710,424 $53.7 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $4.84 Million - $5.79 Million
-68,779 Reduced 8.88%
706,039 $57.1 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $223,716 - $240,140
-3,093 Reduced 0.4%
774,818 $65.1 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $407,992 - $425,216
-5,503 Reduced 0.7%
777,911 $66.8 Million
Q2 2017

Aug 14, 2017
BUY
N/A
783,414
783,414 $65.4 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email